Expression of AFPmRNA in blood of patients with recurrent hepatocellular carcinoma

Hepatobiliary Pancreat Dis Int. 2003 May;2(2):274-7.

Abstract

Objectives: To detect the expression of human alpha-fetoprotein mRNA (AFPmRNA) in peripheral blood (PBL) of recurrent hepatocellular carcinoma (HCC) by using nested reverse transcriptase polymerase chain reaction (nested RT-PCR) and to discuss relations between AFPmRNA and recurrent HCC.

Methods: Five ml peripheral blood samples were obtained from 19 patients with recurrent HCC. To identify HCC cells in PBL, liver-specific AFPmRNA was amplified from the total RNA extracted from the whole blood by nested RT-PCR.

Results: Seven patients (36.8%) with recurrent HCC were detected AFPmRNA, and 12 patients with recurrent HCC were AFPmRNA negative (63.2%). There was no significant relation between patients with AFPmRNA positive and AFPmRNA negative (P>0.05) in judging the origin of recurrent HCC.

Conclusion: AFPmRNA may not be used as a marker of origin of recurrent HCC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / blood
  • Biomarkers, Tumor / genetics
  • Carcinoma, Hepatocellular / blood
  • Carcinoma, Hepatocellular / diagnosis*
  • Female
  • Humans
  • Liver Neoplasms / blood
  • Liver Neoplasms / diagnosis*
  • Male
  • Neoplasm Recurrence, Local / blood
  • Neoplasm Recurrence, Local / diagnosis*
  • Polymerase Chain Reaction
  • RNA, Messenger / blood
  • alpha-Fetoproteins / genetics*

Substances

  • Biomarkers, Tumor
  • RNA, Messenger
  • alpha-Fetoproteins